Immunophotonics, Swiss Cancer Institute Complete Ph1b/2a in Tumor
21 Aug 2025 //
PR NEWSWIRE
Immunophotonics Ends Injectabl-1 Trial For Advanced Solid Tumors
31 Jul 2025 //
PR NEWSWIRE
Immunophotonics to Present at the 2024 ThinkEquity Conference
28 Oct 2024 //
#N/A
Immunophotonics Appoints New CMO and CSO
30 Aug 2022 //
EINNEWS